Toll-like receptor 4 signalling is specifically TGF-beta-activated kinase 1 independent in synovial fibroblasts

Rheumatology

Volumn 50, Issue 7, 2011, Pages 1216-1225

  Geurts, Jeroen ^a,c   van den Brand, Ben T ^a   Wolf, Alexander ^b   Abdollahi Roodsaz, Shahla ^a   Arntz, Onno J ^a   Kracht, Michael ^b   van den Berg, Wim B ^a   van de Loo, Fons A J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Nuclear factor B; Rheumatoid arthritis; Signal transduction; Synovial fibroblast; TGF activated kinase 1; Toll like receptor; Transcriptional reporter

Indexed keywords

COLLAGENASE 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; STROMELYSIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR RELA; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; TUMOR NECROSIS FACTOR;

ARTICLE; CLINICAL ARTICLE; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; SYNOVIOCYTE;

ANALYSIS OF VARIANCE; ANIMALS; ARTHRITIS, RHEUMATOID; BLOTTING, WESTERN; CELLS, CULTURED; ENZYME ACTIVATION; FEMALE; FIBROBLASTS; MALE; MAP KINASE KINASE KINASES; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; SYNOVIAL MEMBRANE; TOLL-LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA1;

EID: 79959418133     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ker021     Document Type: Article

References (52)

1. Armaka M, Apostolaki M, Jacques P et al. Mesenchymal cell targeting by TNF as a common pathogenic principle in chronic inflammatory joint and intestinal diseases. J Exp Med 2008;205:331-7.
2. Lee DM, Kiener HP, Agarwal SK et al. Cadherin-11 in synovial lining formation and pathology in arthritis. Science 2007;315:1006-10.
3. Lefevre S, Knedla A, Tennie C et al. Synovial fibroblasts spread rheumatoid arthritis to unaffected joints. Nat Med 2009;15:1414-20.
4. Arntz OJ, Geurts J, Veenbergen S et al. A crucial role for tumor necrosis factor receptor 1 in synovial lining cells and the reticuloendothelial system in mediating experimental arthritis. Arthritis Res Ther 2010;12:R61.
5. Brennan FM, Chantry D, Jackson A et al. Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet 1989;2:244-7.
6. Dayer JM, de Rochemonteix B, Burrus B et al. Human recombinant interleukin 1 stimulates collagenase and prostaglandin E2 production by human synovial cells. J Clin Invest 1986;77:645-8.
7. Brentano F, Schorr O, Gay RE et al. RNA released from necrotic synovial fluid cells activates rheumatoid arthritis synovial fibroblasts via Toll-like receptor 3. Arthritis Rheum 2005;52:2656-65.
8. Ospelt C, Brentano F, Rengel Y et al. Overexpression of Toll-like receptors 3 and 4 in synovial tissue from patients with early rheumatoid arthritis: Toll-like receptor expression in early and longstanding arthritis. Arthritis Rheum 2008;58:3684-92.
9. Pierer M, Rethage J, Seibl R et al. Chemokine secretion of rheumatoid arthritis synovial fibroblasts stimulated by Toll-like receptor 2 ligands. J Immunol 2004;172:1256-65.
10. Radstake TR, Roelofs MF, Jenniskens YM et al. Expression of Toll-like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokines interleukin-12 and interleukin-18 via interferon-gamma. Arthritis Rheum 2004;50:3856-65.
11. Roelofs MF, Boelens WC, Joosten LA et al. Identification of small heat shock protein B8 (HSP22) as a novel TLR4 ligand and potential involvement in the pathogenesis of rheumatoid arthritis. J Immunol 2006;176:7021-7.
12. Abdollahi-Roodsaz S, Joosten LA, Koenders MI et al. Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis. J Clin Invest 2008;118:205-16.
13. Abdollahi-Roodsaz S, Joosten LA, Koenders MI et al. Local interleukin-1-driven joint pathology is dependent on Toll-like receptor 4 activation. Am J Pathol 2009;175: 2004-13.
14. Hammaker D, Sweeney S, Firestein GS. Signal transduction networks in rheumatoid arthritis. Ann Rheum Dis 2003;62(Suppl 2):ii86-9.
15. Hammaker DR, Boyle DL, Chabaud-Riou M et al. Regulation of c-Jun N-terminal kinase by MEKK-2 and mitogen-activated protein kinase kinase kinases in rheumatoid arthritis. J Immunol 2004;172:1612-8.
16. Sato S, Sanjo H, Takeda K et al. Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat Immunol 2005;6:1087-95.
17. Shim JH, Xiao C, Paschal AE et al. TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. Genes Dev 2005;19:2668-81.
18. Takaesu G, Surabhi RM, Park KJ et al. TAK1 is critical for IkappaB kinase-mediated activation of the NF-kappaB pathway. J Mol Biol 2003;326:105-15.
19. Ninomiya-Tsuji J, Kajino T, Ono K et al. A resorcylic acid lactone, 5Z-7-oxozeaenol, prevents inflammation by inhibiting the catalytic activity of TAK1 MAPK kinase kinase. J Biol Chem 2003;278:18485-90.
20. Shim JH, Greenblatt MB, Xie M et al. TAK1 is an essential regulator of BMP signalling in cartilage. EMBO J 2009;28: 2028-41.
21. Omori E, Matsumoto K, Sanjo H et al. TAK1 is a master regulator of epidermal homeostasis involving skin inflammation and apoptosis. J Biol Chem 2006;281:19610-7.
22. Kajino-Sakamoto R, Inagaki M, Lippert E et al. Enterocyte-derived TAK1 signaling prevents epithelium apoptosis and the development of ileitis and colitis. J Immunol 2008;181:1143-52.
23. Inokuchi S, Aoyama T, Miura K et al. Disruption of TAK1 in hepatocytes causes hepatic injury, inflammation, fibrosis, and carcinogenesis. Proc Natl Acad Sci USA 2010;107: 844-9.
24. Hammaker DR, Boyle DL, Inoue T et al. Regulation of the JNK pathway by TGF-beta activated kinase 1 in rheumatoid arthritis synoviocytes. Arthritis Res Ther 2007;9:R57.
25. Huber R, Hummert C, Gausmann U et al. Identification of intra-group, inter-individual, and gene-specific variances in mRNA expression profiles in the rheumatoid arthritis synovial membrane. Arthritis Res Ther 2008;10:R98.
26. Zimmermann T, Kunisch E, Pfeiffer R et al. Isolation and characterization of rheumatoid arthritis synovial fibroblasts from primary culture-primary culture cells markedly differ from fourth-passage cells. Arthritis Res Ther 2001;3:72-6.
27. Geurts J, Joosten LA, Takahashi N et al. Computational design and application of endogenous promoters for transcriptionally targeted gene therapy for rheumatoid arthritis. Mol Ther 2009;17:877-87.
28. Hoffmann E, Thiefes A, Buhrow D et al. MEK1-dependent delayed expression of Fos-related antigen-1 counteracts c-Fos and p65 NF-kappaB-mediated interleukin-8 transcription in response to cytokines or growth factors. J Biol Chem 2005;280:9706-18.
29. Thiefes A, Wolter S, Mushinski JF et al. Simultaneous blockade of NFkappaB, JNK, and p38 MAPK by a kinase-inactive mutant of the protein kinase TAK1 sensitizes cells to apoptosis and affects a distinct spectrum of tumor necrosis factor target genes. J Biol Chem 2005;280:27728-41.
30. Flavell SJ, Hou TZ, Lax S et al. Fibroblasts as novel therapeutic targets in chronic inflammation. Br J Pharmacol 2008;153(Suppl 1):S241-6.
31. Han Z, Boyle DL, Chang L et al. c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J Clin Invest 2001; 108:73-81.
32. Tzima S, Victoratos P, Kranidioti K et al. Myeloid heme oxygenase-1 regulates innate immunity and autoimmunity by modulating IFN-beta production. J Exp Med 2009;206: 1167-79.
33. Johnson GL, Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002;298:1911-2.
34. Noss EH, Brenner MB. The role and therapeutic implications of fibroblast-like synoviocytes in inflammation and cartilage erosion in rheumatoid arthritis. Immunol Rev 2008;223:252-70.
35. Fraczek J, Kim TW, Xiao H et al. The kinase activity of IL-1 receptor-associated kinase 4 is required for interleukin-1 receptor/Toll-like receptor-induced TAK1-dependent NFkappaB activation. J Biol Chem 2008;283:31697-705.
36. Di Y, Li S, Wang L et al. Homeostatic interactions between MEKK3 and TAK1 involved in NF-kappaB signaling. Cell Signal 2008;20:705-13.
37. Dong W, Liu Y, Peng J et al. The IRAK-1-BCL10-MALT1-TRAF6-TAK1 cascade mediates signaling to NF-kappaB from Toll-like receptor 4. J Biol Chem 2006; 281:26029-40.
38. Gao D, Wang R, Li B et al. WDR34 is a novel TAK1-associated suppressor of the IL-1R/TLR3/TLR4-induced NF-kappaB activation pathway. Cell Mol Life Sci 2009;66:2573-84.
39. Kumar H, Kawai T, Akira S. Toll-like receptors and innate immunity. Biochem Biophys Res Commun 2009;388: 621-5.
40. Yamamoto M, Sato S, Hemmi H et al. Role of adaptor TRIF in the MyD88-independent Toll-like receptor signaling pathway. Science 2003;301:640-3.
41. Qin J, Yao J, Cui G et al. TLR8-mediated NF-kappaB and JNK activation are TAK1-independent and MEKK3-dependent. J Biol Chem 2006;281:21013-21.
42. Yao J, Kim TW, Qin J et al. Interleukin-1 (IL-1)-induced TAK1-dependent versus MEKK3-dependent NFkappaB activation pathways bifurcate at IL-1 receptor-associated kinase modification. J Biol Chem 2007;282:6075-89.
43. Medvedev AE, Lentschat A, Wahl LM et al. Dysregulation of LPS-induced Toll-like receptor 4-MyD88 complex formation and IL-1 receptor-associated kinase 1 activation in endotoxin-tolerant cells. J Immunol 2002;169: 5209-16.
44. Piao W, Song C, Chen H et al. Endotoxin tolerance dysregulates MyD88- and Toll/IL-1R domain-containing adapter inducing IFN-{beta}-dependent pathways and increases expression of negative regulators of TLR signaling. J Leukoc Biol 2009;86:863-75.
45. Medvedev AE, Kopydlowski KM, Vogel SN. Inhibition of lipopolysaccharide-induced signal transduction in endotoxin-tolerized mouse macrophages: dysregulation of cytokine, chemokine, and Toll-like receptor 2 and 4 gene expression. J Immunol 2000;164:5564-74.
46. Mandrekar P, Bala S, Catalano D et al. The opposite effects of acute and chronic alcohol on lipopolysaccharide-induced inflammation are linked to IRAK-M in human monocytes. J Immunol 2009;183: 1320-7.
47. van't Veer C, van den Pangaart PS, van Zoelen MA et al. Induction of IRAK-M is associated with lipopolysaccharide tolerance in a human endotoxemia model. J Immunol 2007;179:7110-20.
48. Guo B, Cheng G. Modulation of the interferon antiviral response by the TBK1/IKKi adaptor protein TANK. J Biol Chem 2007;282:11817-26.
49. Sanz L, Diaz-Meco MT, Nakano H et al. The atypical PKC-interacting protein p62 channels NF-kappaB activation by the IL-1-TRAF6 pathway. EMBO J 2000;19: 1576-86.
50. Shimizu H, Yamamoto K. NF-kappa B and C/EBP transcription factor families synergistically function in mouse serum amyloid A gene expression induced by inflammatory cytokines. Gene 1994;149:305-10.
51. Bing Z, Huang JH, Liao WS. NFkappa B interacts with serum amyloid A3 enhancer factor to synergistically activate mouse serum amyloid A3 gene transcription. J Biol Chem 2000;275:31616-23.
52. Sacre SM, Andreakos E, Kiriakidis S et al. The Toll-like receptor adaptor proteins MyD88 and Mal/TIRAP contribute to the inflammatory and destructive processes in a human model of rheumatoid arthritis. Am J Pathol 2007;170:518-25.